Stock Scorecard



Stock Summary for Conmed Corp (CNMD) - $54.01 as of 8/13/2025 3:14:24 PM EST

Total Score

15 out of 30

Safety Score

39 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for CNMD

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for CNMD

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for CNMD

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for CNMD

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for CNMD (39 out of 100)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 8
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 3
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 9
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for CNMD

Why Conmed ( CNMD ) is a Top Momentum Stock for the Long-Term 8/12/2025 1:50:00 PM
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick 8/6/2025 1:40:00 PM
Why Conmed ( CNMD ) is a Top Growth Stock for the Long-Term 8/5/2025 1:45:00 PM
Conmed ( CNMD ) Q2 EPS Jumps 17% 7/31/2025 6:44:00 PM
CONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised 7/31/2025 5:25:00 PM
Conmed ( CNMD ) Q2 Earnings and Revenues Top Estimates 7/30/2025 10:00:00 PM
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now 7/10/2025 12:19:00 PM
Why Is Merit Medical Stock Trading Higher On Tuesday? - Merit Medical Systems ( NASDAQ:MMSI ) 7/8/2025 12:34:00 PM
Merit Medical Names Martha Aronson as New President and Chief Executive Officer - Merit Medical Systems ( NASDAQ:MMSI ) 7/7/2025 8:05:00 PM
This Conagra Brands Analyst Turns Bearish; Here Are Top 3 Downgrades For Thursday - Anglogold Ashanti ( NYSE:AU ) , Conagra Brands ( NYSE:CAG ) 6/12/2025 1:10:00 PM

Financial Details for CNMD

Company Overview

Ticker CNMD
Company Name Conmed Corp
Country N/A
Description CONMED Corporation, a medical technology company, develops, manufactures and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company is headquartered in Largo, Florida.
Sector Name LIFE SCIENCES
Industry Name ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Most Recent Quarter 6/30/2025
Next Earnings Date 10/22/2025

Stock Price History

Last Day Price 54.01
Price 4 Years Ago 137.11
Last Day Price Updated 8/13/2025 3:14:24 PM EST
Last Day Volume 458,353
Average Daily Volume 536,650
52-Week High 77.23
52-Week Low 45.83
Last Price to 52 Week Low 17.85%

Valuation Measures

Trailing PE 15.44
Industry PE 17.28
Sector PE 57.42
5-Year Average PE 29.53
Free Cash Flow Ratio 49.10
Industry Free Cash Flow Ratio 20.33
Sector Free Cash Flow Ratio 30.31
Current Ratio Most Recent Quarter 2.23
Total Cash Per Share 1.10
Book Value Per Share Most Recent Quarter 32.41
Price to Book Ratio 1.69
Industry Price to Book Ratio 2.98
Sector Price to Book Ratio 28.40
Price to Sales Ratio Twelve Trailing Months 1.28
Industry Price to Sales Ratio Twelve Trailing Months 3.89
Sector Price to Sales Ratio Twelve Trailing Months 32.19
Analyst Buy Ratings 0
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 30,955,000
Market Capitalization 1,671,879,550
Institutional Ownership 115.34%

Dividends

Ex-Dividend Date 9/15/2025
Previous Dividend Amount 0.2000
Current Dividend Amount 0.2000
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.80
Trailing Annual Dividend Yield 1.46%
Forward Annual Dividend Rate 0.80
Forward Annual Dividend Yield 1.46%
5-Year Dividend Payments Count 21
3-Year Average Dividend Yield 1.18%
5-Year Average Dividend Yield 0.86%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 2.43%
Dividend Payout Ratio 22.60%

Income Statement

Quarterly Earnings Growth YOY -28.10%
Annual Earnings Growth 105.44%
Reported EPS 12 Trailing Months 3.54
Reported EPS Past Year 2.10
Reported EPS Prior Year 4.16
Net Income Twelve Trailing Months 110,196,000
Net Income Past Year 132,423,000
Net Income Prior Year 64,459,000
Quarterly Revenue Growth YOY 3.10%
5-Year Revenue Growth 6.47%
Operating Margin Twelve Trailing Months 10.60%

Balance Sheet

Total Cash Most Recent Quarter 33,935,000
Total Cash Past Year 24,459,000
Total Cash Prior Year 24,296,000
Net Cash Position Most Recent Quarter -847,176,000
Net Cash Position Past Year -880,607,000
Long Term Debt Past Year 905,066,000
Long Term Debt Prior Year 973,140,000
Total Debt Most Recent Quarter 881,111,000
Equity to Debt Ratio Past Year 0.52
Equity to Debt Ratio Most Recent Quarter 0.53
Total Stockholder Equity Past Year 962,681,000
Total Stockholder Equity Prior Year 834,222,000
Total Stockholder Equity Most Recent Quarter 1,002,870,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 148,242,000
Free Cash Flow Per Share Twelve Trailing Months 4.79
Free Cash Flow Past Year 153,884,000
Free Cash Flow Prior Year 106,316,000

Options

Put/Call Ratio 0.17
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.31
MACD Signal -0.27
20-Day Bollinger Lower Band 47.36
20-Day Bollinger Middle Band 53.55
20-Day Bollinger Upper Band 59.74
Beta 1.17
RSI 59.25
50-Day SMA 62.25
150-Day SMA 82.67
200-Day SMA 91.88

System

Modified 8/13/2025 8:49:16 PM EST